The time needed to achieve normalization of GH and IGF-1 levels has also been studied; it was achieved after a median follow-up of 4.9 months (range 1.2–117) in 53 patients with active acromegaly under treatment with lanreotide ATG. This evidence concerns the gene GH1 and acromegaly.